[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Qinghai Gelatin Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Qinghai Gelatin Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

QLT Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

QLT Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

QRxPharma Pty Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

QRxPharma Pty Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Quantum Genomics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quantum Genomics Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Quest PharmaTech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quest PharmaTech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Questcor Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Questcor Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 72 pages

Quick-Med Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quick-Med Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

R-Tech Ueno Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

R-Tech Ueno Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Radient Pharmaceuticals Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Radient Pharmaceuticals Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Ranaz Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ranaz Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Ranbaxy Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ranbaxy Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Raptor Pharmaceuticals Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Raptor Pharmaceuticals Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Re Yon Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Re Yon Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Read-Gene SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Read-Gene SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Recordati SpA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Recordati SpA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Redpoint Bio Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Redpoint Bio Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Reflect Scientific, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reflect Scientific, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

ReGen Biologics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ReGen Biologics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

ReGen Therapeutics plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ReGen Therapeutics plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Regeneron Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regeneron Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Regenerx Biopharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenerx Biopharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Regenicin, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenicin, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Reliance GeneMedix plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reliance GeneMedix plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

ReNeuron Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ReNeuron Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Renhe Pharmacy Co., Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Renhe Pharmacy Co., Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Renovo Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Renovo Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Repligen Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Repligen Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Repros Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Repros Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Response Genetics, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Response Genetics, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Resverlogix Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Resverlogix Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Rexahn Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rexahn Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Reyoung Pharmaceutical Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reyoung Pharmaceutical Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Rigas Farmaceitiska Fabrika Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rigas Farmaceitiska Fabrika Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Rigel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rigel Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

RNL Bio Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RNL Bio Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 73 pages

Roche Holding AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Roche Holding AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Rockwall Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rockwall Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Rohto Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rohto Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Rosetta Genomics, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rosetta Genomics, Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

RPG Life Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RPG Life Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Rubicon Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rubicon Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

RxElite Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RxElite Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

RXi Pharmaceuticals Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RXi Pharmaceuticals Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

S&P Pharmaceutical Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

S&P Pharmaceutical Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Saamya Biotech (India) Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Saamya Biotech (India) Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Salix Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Salix Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sam Chun Dang Pharmacy Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sam Chun Dang Pharmacy Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sam-A Pharm. Co. Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sam-A Pharm. Co. Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Samaritan Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Samaritan Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Samil Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Samil Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers